{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:02:20Z","timestamp":1760781740776},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.neuroscience.2012.12.058","type":"journal-article","created":{"date-parts":[[2013,1,26]],"date-time":"2013-01-26T01:45:48Z","timestamp":1359164748000},"page":"99-109","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Estrogen receptors and lesion-induced response of striatal dopamine receptors"],"prefix":"10.1016","volume":"236","author":[{"given":"S.","family":"Al Sweidi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Morissette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Rouillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Di Paolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2012.12.058_b0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/mds.870120107","article-title":"Long-term changes of striatal dopamine D2 receptors in patients with Parkinson\u2019s disease: a study with positron emission tomography and [11C]raclopride","volume":"12","author":"Antonini","year":"1997","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0015","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0928-0987(00)00170-6","article-title":"Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse","volume":"12","author":"Araki","year":"2001","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0020","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.lfs.2011.03.010","article-title":"The possible role of estrogen and selective estrogen receptor modulators in a rat model of Parkinson\u2019s disease","volume":"88","author":"Baraka","year":"2011","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0025","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.tips.2007.02.006","article-title":"The Akt-GSK-3 signaling cascade in the actions of dopamine","volume":"28","author":"Beaulieu","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cell.2005.05.012","article-title":"An Akt\/beta-arrestin 2\/PP2A signaling complex mediates dopaminergic neurotransmission and behavior","volume":"122","author":"Beaulieu","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.nbd.2004.10.005","article-title":"L-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain","volume":"18","author":"Bezard","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0040","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.tins.2007.03.006","article-title":"Dopamine neuron systems in the brain: an update","volume":"30","author":"Bjorklund","year":"2007","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.tins.2007.03.004","article-title":"Fifty years of dopamine research","volume":"30","author":"Bjorklund","year":"2007","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0055","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.yfrne.2009.04.014","article-title":"Neuroprotective actions of sex steroids in Parkinson\u2019s disease","volume":"30","author":"Bourque","year":"2009","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0060","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1471-4159.2007.04586.x","article-title":"Dopamine depletion and subsequent treatment with L-DOPA, but not the long-lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatum","volume":"102","author":"Bychkov","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0065","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1523\/JNEUROSCI.20-05-01849.2000","article-title":"Activation of extracellular signal-regulated protein kinases is associated with a sensitized locomotor response to D(2) dopamine receptor stimulation in unilateral 6-hydroxydopamine-lesioned rats","volume":"20","author":"Cai","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0070","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/1098-2396(20000915)37:4<245::AID-SYN1>3.0.CO;2-5","article-title":"Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice","volume":"37","author":"Callier","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0075","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/jnr.21024","article-title":"Neuroprotective role of ERK1\/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress","volume":"84","author":"Cavanaugh","year":"2006","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.brainres.2009.12.093","article-title":"The effect of estrogen on dopamine and serotonin receptor and transporter levels in the brain: an autoradiography study","volume":"1321","author":"Chavez","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0085","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.bbr.2008.01.012","article-title":"Hemiparkinsonian rats rotate toward the side with the weaker dopaminergic neurotransmission","volume":"189","author":"Da Cunha","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0090","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.neuropharm.2004.08.020","article-title":"Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ER alpha agonist","volume":"47","author":"D\u2019Astous","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0095","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1124\/mol.105.018671","article-title":"Implication of the phosphatidylinositol-3 kinase\/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice","volume":"69","author":"D\u2019Astous","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0100","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/jnr.20765","article-title":"Role of extracellular-regulated kinase and c-Jun NH2-terminal kinase in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurofilament phosphorylation","volume":"83","author":"De Girolamo","year":"2006","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1515\/REVNEURO.1994.5.1.27","article-title":"Modulation of brain dopamine transmission by sex steroids","volume":"5","author":"Di Paolo","year":"1994","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0110","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1096\/fj.11-194100","article-title":"Redox modification of Akt mediated by the dopaminergic neurotoxin MPTP, in mouse midbrain, leads to down-regulation of pAkt","volume":"26","author":"Durgadoss","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0304-3940(88)90575-7","article-title":"Relation between brain dopamine loss and D2 dopamine receptor density in MPTP monkeys","volume":"86","author":"Falardeau","year":"1988","journal-title":"Neurosci Lett"},{"year":"1997","series-title":"The mouse brain in stereotaxic coordinates","author":"Franklin","key":"10.1016\/j.neuroscience.2012.12.058_b0120"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0125","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0278-5846(95)00110-H","article-title":"Effect of adding the D-1 agonist CY 208\u2013243 to chronic bromocriptine treatment of MPTP-monkeys: regional changes of brain dopamine receptors","volume":"19","author":"Gagnon","year":"1995","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0130","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-neuro-061010-113641","article-title":"Modulation of striatal projection systems by dopamine","volume":"34","author":"Gerfen","year":"2011","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0135","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/archneur.61.5.641","article-title":"The neurobiology of dopamine signaling","volume":"61","author":"Girault","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0140","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0306-4522(96)00689-6","article-title":"Continuous or pulsatile chronic D2 dopamine receptor agonist (U91356A) treatment of drug-naive 4-phenyl-1,2,3,6-tetrahydropyridine monkeys differentially regulates brain D1 and D2 receptor expression: in situ hybridization histochemical analysis","volume":"79","author":"Goulet","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0145","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1523\/JNEUROSCI.20-07-02567.2000","article-title":"Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal","volume":"20","author":"Hetman","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0150","doi-asserted-by":"crossref","first-page":"49577","DOI":"10.1074\/jbc.M111227200","article-title":"ERK1\/2 antagonizes glycogen synthase kinase-3beta-induced apoptosis in cortical neurons","volume":"277","author":"Hetman","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0155","first-page":"229","article-title":"Mechanism of cell death in experimental models of Parkinson\u2019s disease","volume":"15","author":"Hirsch","year":"2000","journal-title":"Funct Neurol"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0160","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1212\/WNL.51.2_Suppl_2.S2","article-title":"Biochemical aspects of Parkinson\u2019s disease","volume":"51","author":"Hornykiewicz","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0165","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0006-8993(88)91523-5","article-title":"Estrogen treatment increases the density of D1 dopamine receptors in the rat striatum","volume":"442","author":"Hruska","year":"1988","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.ne.11.030188.000501","article-title":"MPTP toxicity: implications for research in Parkinson\u2019s disease","volume":"11","author":"Kopin","year":"1988","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0175","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1046\/j.1471-4159.2001.00304.x","article-title":"Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson\u2019s disease","volume":"77","author":"Kulich","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0180","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0304-3940(99)00815-0","article-title":"Expression of estrogen receptor-alpha and beta mRNA in the developing and adult mouse striatum","volume":"276","author":"Kuppers","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0185","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1023\/A:1007165307652","article-title":"Estrogen: a multifunctional messenger to nigrostriatal dopaminergic neurons","volume":"29","author":"Kuppers","year":"2000","journal-title":"J Neurocytol"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0190","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.psyneuen.2008.03.007","article-title":"Functional alterations of the nigrostriatal dopamine system in estrogen receptor-alpha knockout (ERKO) mice","volume":"33","author":"Kuppers","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0195","first-page":"1916","article-title":"PET studies on dopamine D1 receptors in the human brain with carbon-11-SCH 39166 and carbon-11-NNC 756","volume":"35","author":"Laihinen","year":"1994","journal-title":"J Nucl Med"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0200","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000065951","article-title":"Estrogenic properties of raloxifene, but not tamoxifen, on D2 and D3 dopamine receptors in the rat forebrain","volume":"76","author":"Landry","year":"2002","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0205","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science (NY)"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0210","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neuropharm.2005.10.004","article-title":"ERbeta mediates the estradiol increase of D2 receptors in rat striatum and nucleus accumbens","volume":"50","author":"Le Saux","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0215","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: from structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiol Rev"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0220","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1210\/en.2002-221069","article-title":"Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha","volume":"144","author":"Mitra","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0225","first-page":"1073","article-title":"Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine","volume":"50","author":"Morissette","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0230","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.neuropharm.2007.02.004","article-title":"Role of estrogen receptors in neuroprotection by estradiol against MPTP toxicity","volume":"52","author":"Morissette","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0235","first-page":"480","article-title":"Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study","volume":"42","author":"Morissette","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0240","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.pnpbp.2009.12.011","article-title":"Striatal Akt\/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys","volume":"34","author":"Morissette","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0245","first-page":"153","article-title":"Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions","volume":"22","author":"Pearson","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0255","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1097\/00001756-199908020-00035","article-title":"Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation","volume":"10","author":"Perry","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0260","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","article-title":"The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety","volume":"76","author":"Przedborski","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0335","series-title":"Dementia with Lewy Bodies: Clinical, Pathological and Treatment Issues","first-page":"449","article-title":"Neurochemical correlates of pathological and iatrogenic extrapyramidal symptoms","author":"Piggott","year":"1996"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0270","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/mds.870120204","article-title":"The effect of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in the striatum of parkinsonian monkeys","volume":"12","author":"Rioux","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0275","first-page":"429","article-title":"Dopamine autoreceptors: pharmacology, function and comparison with post-synaptic dopamine receptors","volume":"3","author":"Roth","year":"1979","journal-title":"Commun Psychopharmacol"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0280","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1111\/j.1755-5949.2010.00163.x","article-title":"Steroids-dopamine interactions in the pathophysiology and treatment of CNS disorders","volume":"16","author":"Sanchez","year":"2010","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0285","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.psyneuen.2011.06.012","article-title":"Effect of a chronic treatment with 17beta-estradiol on striatal dopamine neurotransmission and the Akt\/GSK3 signaling pathway in the brain of ovariectomized monkeys","volume":"37","author":"Sanchez","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0295","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.2174\/092986711795029546","article-title":"Schizophrenia: a systematic review of the disease state, current therapeutics and their molecular mechanisms of action","volume":"18","author":"Shin","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0300","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0306-4522(99)00520-5","article-title":"Estrogen binding and estrogen receptor characterization (ERalpha and ERbeta) in the cholinergic neurons of the rat basal forebrain","volume":"96","author":"Shughrue","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0305","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1550-8579(07)80003-9","article-title":"Gender differences in Parkinson\u2019s disease","volume":"4","author":"Shulman","year":"2007","journal-title":"Gend Med"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0310","first-page":"149","article-title":"The role of dopamine in modulating the structure and function of striatal circuits","volume":"183","author":"Surmeier","year":"2010","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0315","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1017\/S146114571100109X","article-title":"The dopamine D2 receptor regulates Akt and GSK-3 via Dvl-3","volume":"15","author":"Sutton","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0320","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1212\/WNL.49.3.717","article-title":"In vivo studies on striatal dopamine D1 and D2 site binding in L-dopa-treated Parkinson\u2019s disease patients with and without dyskinesias","volume":"49","author":"Turjanski","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0325","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp.2003.020982","article-title":"Are men at greater risk for Parkinson\u2019s disease than women?","volume":"75","author":"Wooten","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neuroscience.2012.12.058_b0330","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1126\/science.270.5240.1326","article-title":"Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis","volume":"270","author":"Xia","year":"1995","journal-title":"Science"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452213000183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452213000183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T22:42:36Z","timestamp":1562625756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452213000183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":62,"alternative-id":["S0306452213000183"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2012.12.058","relation":{},"ISSN":["0306-4522"],"issn-type":[{"type":"print","value":"0306-4522"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}